Structure-based design of agents targeting the bacterial ribosome

Justin Bower, Martin Drysdale, Richard Hebdon, Allan Jordan, Georg Lentzen, Natalia Matassova, Alastair Murchie, Jenifer Powles, Stephen Roughley

Research output: Contribution to journalArticlepeer-review

Abstract

Rational structure-based drug design has been applied to the antibiotic thiostrepton, in an attempt to overcome some of its' limitations. The identification of a proposed binding fragment allowed construction of a number of key fragments, which were derivatised to generate a library of potential antibiotics. These were then evaluated to determine their ability to bind to the L11 binding domain of the prokaryotic ribosome and inhibit bacterial protein translation.

Original languageEnglish
Pages (from-to)2455-8
Number of pages4
JournalBioorg. Med. Chem. Lett.
Volume13
Issue number15
Publication statusPublished - 4 Aug 2003

Keywords

  • Anti-Bacterial Agents
  • Bacteria
  • Drug Design
  • Escherichia coli
  • Indicators and Reagents
  • Methylation
  • Microbial Sensitivity Tests
  • Protein Biosynthesis
  • RNA, Ribosomal
  • Ribosomes
  • Structure-Activity Relationship
  • Thiostrepton

Fingerprint

Dive into the research topics of 'Structure-based design of agents targeting the bacterial ribosome'. Together they form a unique fingerprint.

Cite this